Anzeige
Mehr »
Login
Sonntag, 02.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Goldman Sachs "kann Bitcoin nicht besitzen" - doch dieses Unternehmen hat einen besseren Weg gefunden…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14156 | ISIN: GB00BYMT0J19 | Ticker-Symbol: LIA
Frankfurt
31.01.25
08:09 Uhr
48,800 Euro
0,000
0,00 %
1-Jahres-Chart
LIVANOVA PLC Chart 1 Jahr
5-Tage-Chart
LIVANOVA PLC 5-Tage-Chart
RealtimeGeldBriefZeit
47,80048,80001.02.
47,80048,60031.01.

Aktuelle News zur LIVANOVA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.01.LivaNova PLC: LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results274LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday, February 25, 2025 at 1 p.m....
► Artikel lesen
06.01.LivaNova PLC: LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer357LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as Chief Human Resources Officer (CHRO), effective January 14....
► Artikel lesen
18.12.24LivaNova PLC: RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression269Results published in two articles in Brain Stimulation LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Brain Stimulation has published...
► Artikel lesen
05.12.24LivaNova PLC: LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting193LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, taking place December 6-10 in...
► Artikel lesen
19.11.24Livanova's aura6000 Shows Promise for Obstructive Sleep Apnea6
18.11.24LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint2
14.11.24LivaNova PLC: LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences178LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present a general business update during fireside chats...
► Artikel lesen
11.11.24LivaNova nerve stim for sleep apnea meets primary study endpoints1
LIVANOVA Aktie jetzt für 0€ handeln
11.11.24LivaNova meldet positive Ergebnisse in Schlafapnoe-Studie4
11.11.24LivaNova reports positive results in sleep apnea trial1
01.11.24LivaNova maintains VNS Therapy classification2
01.11.24LivaNova behält Klassifizierung für VNS-Therapie bei3
01.11.24LivaNova PLC - 8-K, Current Report3
30.10.24LivaNova beats Q3 expectations, raises 2024 guidance2
30.10.24LivaNova übertrifft Erwartungen im dritten Quartal und hebt Prognose für 2024 an3
30.10.24LivaNova PLC Non-GAAP EPS of $0.90, revenue of $318.1M2
30.10.24LivaNova PLC: LivaNova Reports Third-Quarter 2024 Results319LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2024 and raised full-year 2024 guidance. Financial Summary...
► Artikel lesen
08.10.24LivaNova appoints Susan Podlogar to its board2
08.10.24LivaNova PLC - 8-K, Current Report2
04.10.24LivaNova's New Strategy Could Unlock Revenue, Profit Gains, Analyst Predicts1
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1